NattoPharma ASA

NattoPharma ASA

General
Jobs 0
Shortlists/Awards 1
Pricing strategy 0
Partners/Competitors 0
Last update: Dec 6, 2024 Last update: Dec 6, 2024
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors

Details

Legal residence:Norway
Organization type:Consulting organization
Funding agencies:Other, Government
Other, Government
Sectors:Health, Laboratory & Measurement, Science & Innov ...
See more
Health, Laboratory & Measurement, Science & Innovation
Sanctions:Check now
Status:
Active

Attachments 0

About

NattoPharma ASA is a privately owned Norwegian nutraceutical company founded in 2004 and based in Oslo. Our branded substance is MenaQ7, the natural vitamin K2 - extracted from Natto. This is the most bioavailable and bioeffective form of vitamin K2. MenaQ7 product is a unique product based upon extensive scientific research and documentation in the area of bone and vascular health.

NattoPharma has a R&D agreement with VitaK managed by Professors Cees Vermeer and Leon Schurgers of the Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, the Netherlands. Along with contact to other outstanding medical institutions secures explorative- as well as clinical results for our present recommendations and future use of MenaQ7. We are proud and excited to follow the research which is going on in the biochemical and clinical environments with regards to Vitamin K2. Regulatory affairs are taken care of from Oslo where we follow up on EU directives and regulations.

NattoPharma is presently selling in Europe and in North America having customers in the food supplement and fortified food markets. Our agent in the US P L Thomas is active in the US while NattoPharma services other customers directly. We offer MenaQ7 in both an oil as well as a powder formulation.

Awards

Top partners

Top competitors

Want to unlock full information?
Register with us or sign in to access the organization database.
Similar Companies